Stocks Clock Fourth...
Health Care: Drugs
Astex Pharmaceuticals Inc (ASTX: NASDAQ)
$5.48 -0.11 | -1.97%
05/20/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 8.25M | 5.54M | 16.27M | 4.74M |
| Operating Gains/Losses | -3.34M | -625.00K | -700.00K | -500.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 2.56M | -2.90M | 864.00K | -818.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 121.00K | 112.00K |
| (Decrease) Increase In Payables | -1.95M | 2.48M | -485.00K | -1.12M |
| (Decrease) Increase In Other Current Liabilities | -6.38M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -1.43M | -1.64M | -560.00K | 2.37M |
| Other Non-Cash Items | 10.85M | 3.60M | 1.43M | 2.51M |
| Net Cash From Continuing Operations | 18.02M | 12.35M | 18.00M | 8.69M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 18.02M | 12.35M | 18.00M | 8.69M |
| Sale of Property, Plant & Equipment | 700.00K | 801.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 138.00M | 98.55M | 168.95M | 81.20M |
| Purchases of Property, Plant & Equipment | -1.03M | -1.38M | -1.01M | -989.00K |
| Acquisitions | -12.27M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -168.99M | -95.27M | -169.11M | -133.31M |
| Other Cash from Investing Activities | 0.00 | -269.00K | 700.00K | 500.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -43.60M | 2.44M | -460.00K | -52.60M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 715.00K | 434.00K | 336.00K | 2.68M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 715.00K | 434.00K | 336.00K | 2.68M |
| Effect of Exchange Rate Changes | 568.00K | -990.00K | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -24.29M | 14.23M | 17.87M | -41.23M |
Portfolios with ASTX
- Portfolio NameUser Type
- UserMy SP portfolio
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserGopher Gold
- ContributorStocks Under-$10 Moving Hig...
Latest ASTX Headlines from TheStreet
- Astex Pharmaceuticals To Present At UBS Global Healthcare Conference 05.14.13 | 06:05 am
- Short Interest Moves 16% Higher For ASTX 05.10.13 | 03:05 pm
- Astex Pharmaceuticals Inc Stock Downgraded (ASTX) 05.01.13 | 05:05 am
- Astex Pharmaceuticals Reports 2013 First Quarter Financial Results 04.29.13 | 04:04 pm
- Astex Pharmaceuticals To Present At Needham Healthcare Conference 04.23.13 | 06:04 am
- Astex Pharmaceuticals To Announce 2013 First Quarter Financial Results On April 29th 04.22.13 | 06:04 am
- Astex Pharmaceuticals Provides SGI-110 Update 04.10.13 | 06:04 am
- Investing 'Systems' Take the Guesswork Out of Making Money 04.04.13 | 06:04 am
- Astex Pharmaceuticals Pipeline Data Presentations At AACR 04.03.13 | 06:04 am
- Astex Pharmaceuticals To Present At ROTH Conference 03.12.13 | 06:03 am
Press Releases for ASTX
- Astex Pharmaceuticals To Present At AACR Annual Meeting - Business Wire 03.29.12 | 06:03 am
- Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda - Business Wire 03.21.12 | 06:03 am
- Eisai Inc. Receives Complete Response Letter From The U.S. Food And Drug Administration For Dacogen® (decitabine) For Injection SNDA In Acute Myeloid Leukemia - Business Wire 03.06.12 | 09:03 pm
- Astex Pharmaceuticals Reports 2011 Fourth Quarter And Year-End Financial Results - Business Wire 03.05.12 | 04:03 pm
- Astex Pharmaceuticals To Announce 2011 Fourth Quarter And Year-End Financial Results On March 5, 2012 - Business Wire 02.28.12 | 06:02 am
- Astex Pharmaceuticals To Host Annual Analyst And Investor Day On March 27, 2012 - Business Wire 02.16.12 | 06:02 am
- FDA’s Oncologic Drugs Advisory Committee (ODAC) Votes To Not Support Benefit/Risk Profile Of DACOGEN® (decitabine) In Acute Myeloid Leukemia - Business Wire 02.09.12 | 01:02 pm
- Astex Pharmaceuticals Announces Presentations At Upcoming Conferences - Business Wire 02.06.12 | 06:02 am
- Astex Announces Early Transfer Of Epigenetics Project To GSK - Business Wire 01.16.12 | 06:01 am
- Astex Pharmaceuticals To Present At Biotech Showcase On January 9th - Business Wire 01.03.12 | 06:01 am
Partner Headlines for ASTX
- Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum - Seeking Alpha 01.10.13 | 09:01 am
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop - Seeking Alpha 09.10.12 | 09:09 am
- One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers - Seeking Alpha 07.21.12 | 06:07 am
- 3 Rising Biotech Stars All Under $2/Share - Seeking Alpha 06.18.12 | 09:06 am
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
